Sign In
- Home
- Share Prices
- AQSE Share Prices
- Euronext
- US Share Prices
- Stock Tips
- Share Chat
- FX
- News & RNS
- Media
- Trading Brokers
- Finance Tools
- Members
Latest Share Chat
MaxCyte Share News (MXCT)
MXCT Share
Price
MXCT Share
News
MXCT Share
Chat
MXCT Share
Trades63
MXCT
Live RNS
MXCT Share
Charts
MXCT Broker
Ratings
MXCT Directors
Deals
MXCT Financial
Diary
MXCT
Fundamentals
MXCT Short
Positions
MXCT
Media
MXCT Company
Research
MXCT Company
Timeline
- There is currently no data for MXCT
MaxCyte News
TRADING UPDATES: MaxCyte strikes deal; Barkby sells Workshop
(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Tuesday and not separately reported by Alliance News:
MaxCyte inks deal with Vittoria Therapeutics for cellular therapies
(Alliance News) - MaxCyte Inc on Monday said it signed a strategic platform licence with Vittoria Biotherapeutics to advance cellular therapies.
MaxCyte signs licence deal with Vittoria Biotherapeutics
(Sharecast News) - MaxCyte announced a strategic platform licence agreement with Vittoria Biotherapeutics on Monday, granting Vittoria non-exclusive c...
MaxCyte inks platform licensing deal with Lyell
(Sharecast News) - Cell engineering platform technology company MaxCyte announced a strategic platform licence (SPL) agreement with Lyell Immunopharma...
MaxCyte inks strategic platform license with Lyell Immunopharma
(Alliance News) - MaxCyte Inc on Thursday said it has signed a strategic platform license with Lyell Immunopharma Inc, a clinical stage T cell reprogr...
MaxCyte revises guidance after weaker first quarter
(Sharecast News) - Cell engineering specialist MaxCyte saw its shares slide on Thursday, after it updated its revenue guidance for the year on the bac...
MaxCyte revenue declines, operating loss widens as costs increase
(Alliance News) - MaxCyte Inc on Thursday reported a widened operating loss in the first quarter of 2023 as revenue fell and costs were higher.
Follow the stocks
